1974 - Fellow of Alfred P. Sloan Foundation
His primary areas of study are Estrogen receptor, Internal medicine, Estrogen receptor alpha, Endocrinology and Stereochemistry. His Estrogen receptor research includes elements of Agonist, Receptor, Biochemistry and Estrogen. The various areas that John A. Katzenellenbogen examines in his Internal medicine study include Standardized uptake value and Oncology.
His Estrogen receptor alpha research incorporates elements of Coactivator, Signal transduction, Regulation of gene expression, Diarylpropionitrile and In vivo. His studies deal with areas such as Inflammation, Nuclear receptor, Androgen receptor and Cell biology as well as Endocrinology. His Stereochemistry study integrates concerns from other disciplines, such as Alkylation, Ligand, Ring, Chemical synthesis and Binding site.
Estrogen receptor, Stereochemistry, Internal medicine, Estrogen and Endocrinology are his primary areas of study. John A. Katzenellenbogen has researched Estrogen receptor in several fields, including Receptor, Biochemistry and Ligand. His Receptor research includes themes of Steroid and Progesterone receptor.
His study in Stereochemistry is interdisciplinary in nature, drawing from both Agonist, Structure–activity relationship, Chemical synthesis and Binding site. His Estrogen research is multidisciplinary, incorporating elements of Antiestrogen and Tamoxifen. As part of one scientific family, John A. Katzenellenbogen deals mainly with the area of Endocrinology, narrowing it down to issues related to the In vivo, and often In vitro.
His primary areas of investigation include Estrogen receptor, Internal medicine, Estrogen receptor alpha, Endocrinology and Cancer research. Particularly relevant to Estrogen receptor beta is his body of work in Estrogen receptor. His Estrogen receptor alpha research incorporates themes from Antiestrogen, Receptor, Signal transduction, Regulation of gene expression and In vivo.
His research investigates the link between Endocrinology and topics such as Cell culture that cross with problems in Transgene and Phenotype. The concepts of his Cancer research study are interwoven with issues in Cell growth, Cancer cell, Transcription factor, Breast cancer and Androgen receptor. His study explores the link between Cell biology and topics such as Ligand that cross with problems in Antagonism and Stereochemistry.
John A. Katzenellenbogen mainly investigates Estrogen receptor, Estrogen receptor alpha, Internal medicine, Endocrinology and Cancer research. The study incorporates disciplines such as Estrogen, Pharmacology and Cell growth in addition to Estrogen receptor. His Estrogen receptor alpha research incorporates elements of Tamoxifen, Estrogen receptor beta, Signal transduction, Cell biology and Regulation of gene expression.
His studies in Endocrinology integrate themes in fields like Endometriosis, Lesion, Stromal cell, Angiogenesis and Inflammation. His work deals with themes such as Tumor microenvironment, Cancer cell, Receptor, Cyclin D1 and Breast cancer, which intersect with Cancer research. His Ligand study incorporates themes from Adipose tissue and Stereochemistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture
Yolande Berthois;John A. Katzenellenbogen;Benita S. Katzenellenbogen.
Proceedings of the National Academy of Sciences of the United States of America (1986)
Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity.
S. Kousteni;T. Bellido;L. I. Plotkin;C. A. O'Brien.
Pyrazole Ligands: Structure−Affinity/Activity Relationships and Estrogen Receptor-α-Selective Agonists
Shaun R. Stauffer;Christopher J. Coletta;Rosanna Tedesco;Gisele Nishiguchi.
Journal of Medicinal Chemistry (2000)
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
Marvin J. Meyers;Jun Sun;Kathryn E. Carlson;Gwendolyn A. Marriner.
Journal of Medicinal Chemistry (2001)
The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
Gregory M. Anstead;Kathryn E. Carlson;John A. Katzenellenbogen.
International Union of Pharmacology. LXIV. Estrogen Receptors
Karin Dahlman-Wright;Vincent Cavailles;Suzanne A. Fuqua;V. Craig Jordan.
Pharmacological Reviews (2006)
Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.
John A. Katzenellenbogen;Bert W. O'Malley;Benita S. Katzenellenbogen.
Molecular Endocrinology (1996)
Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Rajeev S Muthyala;Young H Ju;Shubin Sheng;Lee D Williams.
Bioorganic & Medicinal Chemistry (2004)
Breast cancer: PET imaging of estrogen receptors.
M A Mintun;M J Welch;B A Siegel;C J Mathias.
Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.
Ilaria Paterni;Carlotta Granchi;John A. Katzenellenbogen;Filippo Minutolo.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: